Vascular Biogen. Ord (VBLT)
$0.15
0.03 (17.17%)
Why Is Vascular Biogenics (VBLT) Stock Down 80% Today?
The selling pressure on VBLT stock is heavy today as Vascular Biogenics releases the clinical trial results for its ovarian cancer treatment.
11 Best Stocks to Buy for 2023

INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
10.40M
PE Ratio
1.24
EPS
0.12
Volume (Avg. Vol.)
6.87M
Day's Range
$0.15 - $0.20
52-Week Range
$0.10 - $2.20
Dividend & Yield
N/A (N/A)